Novartis AG

    Novartis AG
    $97.11
    SymbolNVS
    Price$97.11
    Change$0.34
    Change %0.35%
    Volume$1,547,658.00
    Marketcap194.15B
    Novartis AG
    Status: Active
    Sector: Healthcare
    Industry: Drug Manufacturers - General
    Symbol: NVS
    Exchange: NYQ
    Employees: 76057
    Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
    Novartis AG
    NYQ
    Healthcare
    Drug Manufacturers - General
    Lichtstrasse 35, Basel, Switzerland
    Switzerland
    41 61 324 1111
    https://www.novartis.com